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1. Introduction
The tooth is a complex biological organ that consists of multiple tissues, including enamel,
dentin, cementum, and pulp. Missing teeth is a common and frequently occurring problem
in aging populations. To treat these defects, the current approach involves fixed or remova‐
ble prostheses, autotransplantation, and dental implants. The exploration of new strategies
for tooth replacement has become a hot topic. Using the foundations of experimental embry‐
ology, developmental and molecular biology, and the principles of biomimetics, tooth re‐
generation is becoming a realistic possibility. Several different methods have been proposed
to achieve biological tooth replacement[1-8]. These include scaffold-based tooth regenera‐
tion, cell pellet engineering, chimeric tooth engineering, stimulation of the formation of a
third dentition, and gene-manipulated tooth regeneration. The idea that a third dentition
might be locally induced to replace missing teeth is an attractive concept[5,8,9]. This ap‐
proach is generally presented in terms of adding molecules to induce de novo tooth initiation
in the mouth. It might be combined with gene-manipulated tooth regeneration; that is, en‐
dogenous dental cells in situ can be activated or repressed by a gene-delivery technique to
produce a tooth. Tooth development is the result of reciprocal and reiterative signaling be‐
tween oral ectoderm-derived dental epithelium and cranial neural crest cell-derived dental
mesenchyme under genetic control [10-12]. More than 200 genes are known to be expressed
during tooth development (http://bite-it.helsinki.fi/). A number of mouse mutants are now
starting to provide some insights into the mechanisms of supernumerary tooth formation.
Multiple supernumerary teeth may have genetic components in their etiology and partially
represent the third dentition in humans. Such candidate molecules or genes might be those
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that are involved in embryonic tooth induction, in successional tooth formation, or in the
control of the number of teeth. This means that it may be possible to induce de novo tooth
formation by the in situ repression or activation of a single candidate gene. In this review,
we present an overview of the collective knowledge of tooth regeneration, especially regard‐
ing the control of the number of teeth for gene therapy by the stimulation of a third denti‐
tion.
2. The third dentition
It has been suggested that, in humans, a “third dentition” with one or more supernumerary
teeth can occur in addition to the permanent dentition, and supernumerary teeth are some‐
times thought to represent a partial post-permanent dentition [13-15]. The basic dentition
pattern observed in mammals is diphyodont, and consists of three incisors, one canine, four
premolars, and three molars, while Human teeth are diphyodont excepting the permanent
molars [16]. The deciduous teeth are, ontogenetically, the first generation of teeth. The per‐
manent teeth (except molar) belong to the second dentition. The term “third dentition” re‐
fers to the opinion that one more set of teeth can occur in addition to the permanent teeth
(Figure 1). Human teeth are diphyodont excepting the permanent molars. The normal
mouse dentition is monophyodont and composed of one incisor and three molars in each
quadrant. The number of teeth is usually strictly determined. It was initially reported that
there is an anlage of the third dentition in some mammals [17]. The presence of an epithelial
anlage of the third dentition was also noticed in humans [18,19]. The teeth and anlagen that
appear in third dentition in serial sections of infant jaws and some fetuses have been ana‐
lyzed. The epithelium which is considered as the anlagen of the third dentition develops lin‐
gual to all permanent tooth germs [15]. Furthermore, when it appears, the predecessor
(permanent tooth germ) is in the bell-shaped stage [15]. The timing of appearance of the
third dentition seems to be after birth (Table 1). This means that we have a chance to access
the formation of the third dentition in the mouth.
Table 1. Timing of appearance of the third dentition
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Figure 1. Multiple impacted supernumerary teeth in a 13-year-old non-syndromic patient. The third dentition devel‐
ops lingual to the permanent tooth germ (D). All impacted supernumerary teeth in this patient are located to the lin‐
gual side of the permanent teeth (white arrow) (A-C). These multiple supernumerary teeth seem to be post-
permanent dentition (“third dentition”).
Analysis of other model systems with continuous tooth replacement or secondary tooth for‐
mation, such as in the fish, snake, lizard, and ferret, is providing insights into the molecular
and cellular mechanisms underlying successional tooth development, and will assist in
studies on supernumerary tooth formation in humans. While some nonmammalian species
have multi rowed dentition and replace their teeth regularly throughout life, mammalian
vertebrates have one row of teeth and only renew their teeth once, or, in some rodents, show
no replacement [20-23]. Detailed histological analysis of the tooth replacement in these mod‐
els indicates that the successional teeth are initiated from the dental lamina epithelium,
which grows from the lingual side of the deciduous tooth enamel organ, and it later elon‐
gates and buds into the jaw mesenchyme, forming successional teeth. Jarvien et al. showed
that, in the ferret, Sostdc1 (also known as USAG-1, ectodin, and Wise) is expressed in the
elongating successional dental lamina at the interface between the lamina and deciduous
tooth, as well as the buccal side of the dental lamina, suggesting that Sostdc1 plays a role in
defining the identity of the dental lamina [20]. Handrigan et al. analyzed successional tooth
formation in the snake and in lizard, and proposed that dental epithelium stem cells are re‐
sponsible for the formation of successional lamina, and Wnt signaling may regulate the stem
cell fate in these cells [24]. Maintenance or reactivation of component dental lamina is thus
pivotal for the replacement tooth and supernumerary formation.
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3. Human syndromes associated with supernumerary teeth
Supernumerary teeth can be associated with a syndrome (Table 2) or they can be found in
non-syndromic patients [25-28]. Only 1% of non-syndromic cases have multiple supernum‐
erary teeth, which occur most frequently in the mandibular premolar area, followed by the
molar and anterior regions, respectively [29-34]. There are special cases exhibiting perma‐
nent supernumerary teeth developing as supplementary teeth forming after the permanent
teeth. These are thought to represent a third dentition, best known as manifestations of clei‐
docranial dysplasia (CCD).
Table 2. Human syndromes associated with supernumerary teeth
Genetic mutations have been associated with the presence or absence of individual types of
teeth. Supernumerary teeth are associated with more than 20 syndromes and developmental
abnormalities like CCD, and Gardner syndrome [35]. The percentage occurrence in CCD is 22%
in the maxillary incisor region and 5% in the molar region[36-38]. CCD is a dominantly inherit‐
ed skeletal dysplasia caused by mutations in Runx2 [39-40]. It is characterized by persistently
open sutures or the delayed closure of sutures, hypoplastic or aplastic clavicles, a short stature,
delayed eruption of permanent dentition, supernumerary teeth, and other skeletal anomalies.
There is a wide spectrum of phenotypic variability ranging from the full-blown phenotype to
an isolated dental phenotype characterized by supernumerary tooth formation and/or the de‐
layed eruption of permanent teeth in CCD (Figure 1) [41-44]. A dose-related effect seems to be
present, as the milder case of CCD, and those exhibiting primary dental anomalies, are related
to mutations that reduce, but do not abolish, protein stability, DNA binding, and transactiva‐
tion [41,43-45]. Runx2-deficient mice were found to exhibit lingualbuds in front of the upper
molars, and these were much more prominent than in wild-type mice[46,47].These buds pre‐
sumably represent the mouse secondary dentition, and it is likely that Runx2 acts to prevent
the formation of these buds. Runx2 usually functions as a cell growth inhibitor[43]. Runx2 reg‐
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ulates the proliferation of cells and may exert specific control on the dental lamina and forma‐
tion of  successive dentitions.  Runx2 heterozygous mutant  mice  mostly  phenocopied the
skeletal defects of CCD in humans, but with no supernumerary tooth formation [48] (Otto,
1997). Notably, in Runx2 homozygous and heterozygous mouse upper molars, a prominent
epithelial bud regularly presents. This epithelial bud protrudes lingually with active Shh sig‐
naling, and it may represent the extension of the dental lamina for successional tooth formation
in mice. Hence, although Runx2 is required for primary tooth development, it prevents the
growth of the dental lamina and successional tooth formation [47].
Familial  adenomatous polyposis (FAP),  also named adenomatous polyposis of  the colon
(APC), is an autosomal dominant hereditary disorder characterized by the development of
many precancerous colorectal adenomatous polyps, some of which will inevitably develop in‐
to cancer. In addition to colorectal neoplasm, individuals can develop variable extracolonic le‐
sions, including upper gastrointestinal polyposis, osteomas, congenital hypertrophy of the
retinal pigment epithelium, soft tissue tumors, desmoid tumors, and dental anomalies [49-53].
Dental abnormalities include impacted teeth, congenital absence of one or more teeth, super‐
numerary teeth, dentigerous cysts associated with the crown of an unerupted tooth, and odon‐
tomas[50,52]. Gardner syndrome is a variant of FAP characterized by multiple adenomas of the
colon and rectum typical of FAP together with osteomas and soft tissue tumors[49,51]. Super‐
numerary teeth and osteomas were originally described as a part of Gardner syndrome, but
they can also occur in FAP patients with or without other extracolonic lesions [51,52]. FAP and
Gardner syndrome are caused by a large number of germinal mutations in the APC gene
[52,53]. APC is a tumor suppressor gene involved in the down-regulation of free intracellular ß-
catenin, the major signal transducer of the canonical Wnt signaling pathway, as well as a cen‐
tral component of the E-cadherin adhesion complex [54,55]. In addition, the APC protein may
also play roles in chromosomal stability, the regulation of cell migration up the colonic crypt
and cell adhesion through association with GSK3ß, and other functions associated with micro‐
tubule bundles [55,56]. Inactivation of APC would lead to the stabilization and accumulation of
the proto-oncogene ß-catenin, dysregulation of the cell cycle, and chromosomal instability [52].
Approximately 11-27% of patients have supernumerary teeth, but, so far, no specific codon
mutation of the APC gene has been found to correlate with supernumerary teeth. Correlations
seem to exist between dental abnormalities and the number and type of osteomas, with the
highest incidence of supernumerary teeth and odontomas being found in FAP patients with
three or more osteomas[52]. Conditional knockout of the Apc-gene resulted in supernumerary
teeth in mice [57-59]. Notably, adult oral tissues, especially young adult tissues, are still respon‐
sive to the loss of Apc[60]. In old adult mice, supernumerary teeth can be induced on both labial
and lingual sides of the incisors, which contain adult stem cells supporting the continuous
growth of mouse incisors [60,61]. In young mice, supernumerary tooth germs were induced in
multiple regions of the jaw in both incisor and molar regions. They can form directly from the
oral epithelium, in the dental lamina connecting the developing molar or incisor tooth germ to
the oral epithelium, in the crown region, as well as in the elongating and furcation area of the
developing root [60].
The identification of mutations in RUNX2 causing an isolated dental phenotype in CCD and
in APC causing FAP has attracted attention as a possible route towards inducing de novo
tooth formation.
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4. Supernumerary tooth formation in a mouse model
The number of teeth is usually strictly determined. Whereas evidence supporting a genetic
etiology for tooth agenesis is well established, the etiology of supernumerary tooth forma‐
tion is only partially understood in the mouse model (Table 3). Unlike humans, mice have
only molars and incisors separated by a toothless region called the diastema. In addition,
mice only have a single primary dentition and their teeth are not replaced. Therefore, mice
may not be an optimal model for studying tooth replacement and supernumerary tooth for‐
mation [62]. Most of the reported mouse supernumerary teeth are located in the diastema
region. This is not a de novo tooth formation but the rescue of vestigial tooth rudiments. Dur‐
ing the early stages of tooth development, many transient vestigial dental buds develop in
the diastema area. Some of them can develop into the bud stage, but later regress and disap‐
pear by apoptosis, or merge with the mesial crown of the first molar tooth [63-68]. Major sig‐
naling pathways regulating tooth development are also expressed in these vestigial dental
buds. Modulation of these signals can rescue these vestigial tooth rudiments to develop into
supernumerary diastema teeth [23]. A number of mutant mouse strains have been reported
exhibiting supernumerary diastema teeth. Although the rudimentary tooth buds form in the
embryonic diastema, they regress apoptically [69]. Transgenic mice in which the keratin 14
promoter directs Ectodysplasin (Eda), a member of the tumor necrosis factor (TNF) family
of signaling molecules, or Eda receptor expression to the epithelium had supernumerary
teeth mesial to the first molar as a result of diastema tooth development [70-72]. It has also
been reported that Sprouty2 (Spry2) or Spry4 (which encode negative feedback regulators of
fibroblast growth factor (FGF)) deficient mice showed supernumerary tooth formation as a
result of diastema tooth development[73]. Hypomorphic Polaris mice and Wnt-Cre (Polaris
conditional mutant mice with affected Shh signaling) [73-74], Pax6 mutant mice [75] and
Gas1 null mutants [73] were also included. Uterine sensitization associated gene-1 (USAG-1)
is a BMP antagonist, and also modulates Wnt signaling. We reported that USAG-1-deficient
mice have supernumerary teeth (Figure 2).
Figure 2. Supernumerary teeth formation in Sostdc 1 (USAG-1) (A-C) and CEBPB (D-H) adult mutant mice. A: Oblique
view of the maxillary incisors. B: Occlusal view of the mandibular incisors. C: Occlusal view of the mandibular molars.
Micro-CT images (D-F) and HE-staining (G,H) of the murine head. A frontal view (D), a sagittal view (E) and a horizontal
view (F) showed supernumerary tooth (red arrow). Two supernumerary teeth and an odontoma were seen in a low
(G) and a high (H) magnification.
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Table 3. Mutant mouse associated with supernumerary teeth
The supernumerary maxillary incisor appears to form as a result of the successive develop‐
ment of the rudimentary upper incisor. USAG-1 abrogation rescued apoptotic elimination of
odontogenic mesenchymal cells [14]. BMP signaling in the rudimentary maxillary incisor, as‐
sessed by expressions of Msx1 and Dlx2 and the phosphorylation of Smad protein, was signifi‐
cantly enhanced. Wnt signaling, as demonstrated by the nuclear localization of β-catenin, was
also up-regulated. The inhibition of BMP signaling rescues supernumerary tooth formation in
E15 incisor explant culture. Based upon these results, we conclude that enhanced BMP signal‐
ing results in supernumerary teeth and BMP signaling was modulated by Wnt signaling in the
USAG-1-deficient mouse model (Figure 3) [76]. Canonical Wnt/β-catenin signaling and its
down-stream molecule Lef-1 are essential for tooth development [77].
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Figure 3. Diagrammatic representation of the Sostdc (USAG-1) pathway during development
Overexpression of Lef-1 under the control of the K14 promoter in transgenic mice leads to
the development abnormal invaginations of the dental epithelium in the mesenchyme and
formation of a tooth-like structure [78]. De novo supernumerary teeth arising directly from
the primary tooth germ or dental lamina have been reported in Apc loss-of-function (as dis‐
cussed in the previous section) or β-catenin gain-of-function mice, and Sp6 (Epiprofin)-defi‐
cient mice. It was demonstrated that mouse tooth buds expressing stabilized β-catenin give
rise to extra teeth[58] (Jarvinen et al., 2006). More recently, Epiprofin (Epfn) (a zinc finger
transcription factor belonging to the Sp transcription factor superfamily)-deficient mice de‐
veloped an excess number of teeth[79]. Mammals only have one row of teeth in each jaw.
Interestingly, in the Osr2 null mutant mouse embryo, supernumerary tooth germs were
found developing directly from the oral epithelium lingual to their molar tooth germs [80].
More recently, we also demonstrated that CEBPB deficiency was related to the formation of
supernumerary teeth[81]. A total of 66.7% of CEBPB-/- 12-month-olds sustained supernumer‐
ary teeth and/or odontomas in the diastema between the incisor and the first molar. Two su‐
pernumerary teeth accompanied with a complex odontoma near the root of the upper right
incisor were identified in a CEBPB-/- adult (Figure 2), whilst two other CEBPB-/- mice simply
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showed a supernumerary tooth in the upper left quadrant. Another CEBPB-/- adult mouse
did not display any supernumerary teeth in either jaw, but an odontoma in the lower-right
quadrant. All of the CEBPB-/- adults appeared with a normal number of erupted incisors and
molars. Nevertheless, 20%of the CEBPB+/- 12-month-olds hada missing lower third molar.
Dental anomalies such as supernumerary teeth, odontomas, or hypodontia were not found
in mice of any other genotypes and/or age[81].
These mouse models clearly demonstrated that it was possible to induce de novo tooth for‐
mation by the in situ repression or activation of single candidate gene such as USAG-1.
5. Gene therapy approaches
Gene therapy provides  a  unique tool  for  the  delivery of  previously  identified signaling
molecules in both time and space that may significantly augment our progress toward clin‐
ical tooth regeneration. Stimulation of the formation of a third dentition and gene-manipu‐
lated  tooth  regeneration  comprise  an  attractive  concept  (Figure  4).  This  approach  is
generally presented in terms of adding molecules to induce de novo tooth initiation in the
mouth. It might be combined with gene-manipulated tooth regeneration; that is, endoge‐
nous dental cells in situ can be activated or repressed by a gene-delivery technique to make
a tooth. We have a chance to access the formation of the third dentition in the mouth, be‐
cause the time of appearance of the third dentition seems to be after birth. As the half-life
of targeted proteins in vivo is transient, tooth regeneration is not a common outcome fol‐
lowing conventional therapy. Typically, high concentrations are required to promote regen‐
eration [82]). Therefore, supplemental local production via gene transfer could be superior
to bolus delivery methods.
Figure 4. In vivo gene delivery approach for the tooth regeneration by stimulation of a third dentition.
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Simply stated, gene therapy consists of the insertion of genes into an individual’s cells di‐
rectly or indirectly with a matrix to promote a specific biological effect. Gene therapy can be
used to induce a more favorable host response. Targeting cells for gene therapy requires the
use of vectors or direct delivery methods to transfect them. To overcome the short half-lives
of peptides in vivo, gene therapy that uses a vector that encodes the candidate genes is uti‐
lized to stimulate the formation of the third dentition. The two main strategies of gene vec‐
tor delivery have been applied. Gene vectors can be introduced directly to the target site (in
vivo gene delivery) [83] or selected cells can be harvested, expanded, genetically transduced,
and then reimplanted (ex vivo gene delivery). In vivo gene transfer involves the insertion of
the gene of interest directly into the body, anticipating the genetic modification of the target
cells. Ex vivo gene transfer includes the incorporation of genetic material into cells exposed
from a tissue biopsy with subsequent reimplantation into the recipient. So far, in vivo gene
delivery has been a suitable gene therapy approach in tooth regeneration by stimulation of
the third dentition, but ex vivo gene delivery is not realistic because of the poor availability
of ideal cells.
Gene transfer  is  accomplished through the  use  of  viral  and nonviral  vectors.  The  three
main classes of virus used for gene therapy are the retrovirus, adenovirus, and adenoas‐
sociated  viruses.  Retroviruses  are  ideal  for  long-term  gene  therapy  since,  once  intro‐
duced,  their  DNA integrates and becomes part  of  the genome of  the host  cells.  Indeed,
the  current  human genome contains  up to  5  to  8% of  endogenous  retroviral  sequences
that have been acquired over the course of  evolution [84].  Adenoviruses are more com‐
monly suited for short-term gene delivery and are highly targeted for tissue engineering
strategies that desire protein production over the course of several weeks.  Efficient ade‐
novirus-directed  gene  delivery  to  odontogenic  mesenchymal  cells  derived  from  cranial
neural crest cells was reported [85,86]. In addition, because the adenovirus is well-known
as  the  “virus  of  the  common  cold,”  infection  is  generally  nontoxic  and  self-limiting.
However,  determination of  the  genotoxicity  for  each specific  application is  necessary to
keep  the  safety  profile  within  acceptable  parameters.  Adenoassociated  viruses  have  be‐
come the  focus  of  much research  in  recent  years  because  of  their  complete  inability  to
replicate  without  a  helper  virus,  potential  for  tissue-specific  targeting,  and gene expres‐
sion  in  the  order  of  months  to  years.  The  ability  to  specifically  target  one  tissue  type
without  adverse  effects  on neighboring tissues  is  highly  desired in  fields  such as  tooth
regeneration. On the other hand, nonviral methods are safe and do not require immuno‐
suppression for  successful  gene delivery,  but  suffer  from lower  transfection efficiencies.
DNA injection followed by application of  electric  fields (electroporation)  has been more
effective for introducing DNA than the use of simple DNA injection [87].  However, this
method involves  the  concern that  the  electric  pulse  causes  tissue  damage.  Recently,  we
reported  that  gene  transfer  using  an  ultra-fine  needle  [88],  in  addition  to  microbubbles
enhanced transcutaneous sonoporation [87].
In vivo gene delivery seems to be a suitable gene therapy approach in tooth regeneration by
stimulation of the third dentition.
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6. Conclusion
We have a chance to access the formation of the third dentition in the mouth, because the
timing of the appearance of the third dentition seems to be after birth. The identification of
mutations in RUNX2 causing an isolated dental phenotype in CCD and supernumerary
tooth formation in the mouse model clearly demonstrated that it was possible to induce de
novo tooth formation by the in situ repression or activation of a single candidate gene. These
results support the idea that the de novo repression or activation of candidate genes such as
RUNX2 or USAG-1 might be used to stimulate the third dentition in order to induce new
tooth formation in the mouse (Figure 4). In vivo gene delivery seems to be a suitable gene
therapy approach in tooth regeneration by stimulation of the third dentition.
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